48 results on '"Cantonwine, David E"'
Search Results
2. 485 Association between perinatal phthalate metabolite concentrations and postpartum glucose levels: a prospective observational study.
- Author
-
Ponzano, Marta, Preston, Emma V., Quinn, Marlee R., Cantonwine, David E., Williams, Paige L., Seely, Ellen W., Wylie, Blair, Hacker, Michele R., Brown, Florence M., O'Brien, Karen, Hauser, Russ, Bellavia, Andrea, Powe, Camille E., McElrath, Thomas, and James-Todd, Tamarra
- Subjects
LONGITUDINAL method ,SCIENTIFIC observation ,GLUCOSE ,PUERPERIUM - Published
- 2024
- Full Text
- View/download PDF
3. 377 Examining the role of angiogenic imbalance via elevated sFlt-1/PLGF in the development of hypertension.
- Author
-
Anwer, Tooba Z., Cantonwine, David E., Seely, Ellen W., Gray, Kathryn J., and McElrath, Thomas
- Subjects
HYPERTENSION - Published
- 2024
- Full Text
- View/download PDF
4. 378 Development of hypertension within 15 years postpartum by phenotype of preeclampsia.
- Author
-
Anwer, Tooba Z., Cantonwine, David E., Seely, Ellen W., Gray, Kathryn J., and McElrath, Thomas
- Subjects
PREECLAMPSIA ,PUERPERIUM ,HYPERTENSION ,PHENOTYPES - Published
- 2024
- Full Text
- View/download PDF
5. Big questions for a bigger data set.
- Author
-
Ferguson, Kelly K., Bommarito, Paige A., Cantonwine, David E., and McElrath, Thomas F.
- Published
- 2023
- Full Text
- View/download PDF
6. Estrogen metabolism pathways in preeclampsia and normal pregnancy.
- Author
-
Cantonwine, David E., McElrath, Thomas F., Trabert, Britton, Xu, Xia, Sampson, Joshua, Roberts, James M., Hoover, Robert N., and Troisi, Rebecca
- Subjects
- *
ESTROGEN , *LIQUID chromatography-mass spectrometry , *METABOLISM , *PREGNANCY , *REPRODUCTIVE technology - Abstract
Highlights • 1st trimester urinary estradiol was elevated in preeclamptic pregnancies. • Absolute concentrations of metabolites were similar between cases and controls. • Ratio of 2- and 4-pathway metabolite to parent estrogens was lower in preeclampsia. • Estrogen metabolism may be reduced in preeclamptic women. Abstract Background Experimental studies suggest that shallow uterine cytotrophoblastic invasion in preeclampsia may be associated with alterations in estrogen metabolism. The objective of this study was to examine the association of parent estrogens and their metabolites between preeclamptics and normotensive controls at three time points during pregnancy. Methods Parent estrogens and their metabolites were measured in urine by high-performance liquid chromatography-tandem mass spectrometry in 66 singleton preeclampsia cases and 137 matched controls. Percent change in geometric means were estimated by general linear models adjusted for gestational age at sampling, maternal age, parity, race, body mass index, and use of assisted reproductive technologies. Results Urinary estradiol concentrations were approximately 50% higher in early pregnancy in preeclampsia cases than controls, but similar late in pregnancy. There was an approximate 20% reduction in total 2-pathway metabolites and 4-pathway metabolites in cases compared with controls in mid- and later pregnancy that was slightly attenuated with adjustment for BMI, and a reduction in 16-pathways in mid-pregnancy but not later. Conclusion(s) Our findings show that estradiol concentrations were elevated in preeclampsia versus controls in early pregnancy. In mid-pregnancy, all three estrogen metabolism (2-, 4-, and 16-) pathways showed some reduction in preeclampsia that appeared to continue for the 2- and 4-pathways in late pregnancy. We hypothesize that this may indicate that there is a generalized reduction in estrogen metabolism in preeclampsia rather than a deficit of specific enzymes, such as those involved in the 2-hydroxylation pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Predictors of upstream inflammation and oxidative stress pathways during early pregnancy.
- Author
-
Welch, Barrett M., Bommarito, Paige A., Cantonwine, David E., Milne, Ginger L., Motsinger-Reif, Alison, Edin, Matthew L., Zeldin, Darryl C., Meeker, John D., McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
- *
OXIDATIVE stress , *UNSATURATED fatty acids , *PREGNANCY , *ARACHIDONIC acid , *OXYLIPINS , *INFLAMMATORY mediators - Abstract
Inflammation and oxidative stress are critical to pregnancy, but most human study has focused on downstream, non-causal indicators. Oxylipins are lipid mediators of inflammation and oxidative stress that act through many biological pathways. Our aim was to characterize predictors of circulating oxylipin concentrations based on maternal characteristics. Our study was conducted among 901 singleton pregnancies in the LIFECODES Fetal Growth Study, a nested case-cohort with recruitment from 2007 to 2018. We measured a targeted panel of oxylipins in early pregnancy plasma and urine samples from several biosynthetic pathways, defined by the polyunsaturated fatty acid (PUFA) precursor and enzyme group. We evaluated levels across predictors, including characteristics of participants' pregnancy, socioeconomic determinants, and obstetric and medical history. Current pregnancy and sociodemographic characteristics were the most important predictors of circulating oxylipins concentrations. Plasma oxylipins were lower and urinary oxylipins higher for participants with a later gestational age at sampling (13–23 weeks), higher prepregnancy BMI (obesity class I, II, or III), Black or Hispanic race and ethnicity, and lower socioeconomic status (younger age, lower education, and uninsured). For example, compared to those with normal or underweight prepregnancy BMI, participants with class III prepregnancy obesity had 45–46% lower plasma epoxy-eicosatrienoic acids, the anti-inflammatory oxylipins produced from arachidonic acid (AA) by cytochrome P450, and had 81% higher urinary 15-series F 2 -isoprostanes, an indicator of oxidative stress produced from non-enzymatic AA oxidation. Similarly, in urine, Black participants had 92% higher prostaglandin E 2 metabolite, a pro-inflammatory oxylipin, and 41% higher 5-series F 2 -isoprostane, an oxidative stress indicator. In this large pregnancy study, we found that circulating levels of oxylipins were different for participants of lower socioeconomic status or of a systematically marginalized racial and ethnic groups. Given associations differed along biosynthetic pathways, results provide insight into etiologic links between maternal predictors and inflammation and oxidative stress. [Display omitted] • Largest study of early pregnancy predictors of upstream inflammatory pathways to date. • Novel assessment of circulating oxylipins in both plasma and urine biospecimens. • Sociodemographic and pregnancy characteristics associate with oxylipin dysregulation. • Vulnerable groups may experience greatest propensity for oxylipin dysregulation. • Results provide insight on biological mechanisms and targets of pregnancy conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Pregnancy urinary bisphenol-A concentrations and glucose levels across BMI categories.
- Author
-
Bellavia, Andrea, Cantonwine, David E., Meeker, John D., Hauser, Russ, Seely, Ellen W., McElrath, Thomas F., and James-Todd, Tamarra
- Subjects
- *
GESTATIONAL diabetes , *PHYSIOLOGICAL effects of chemicals , *BISPHENOL A , *PREGNANCY complications , *GLUCOSE in the body , *BODY mass index - Abstract
Background Pregnancy exposure to bisphenol-A (BPA) may be associated with gestational diabetes (GDM), but evidence from human studies is limited. Moreover, adiposity is associated with both higher BPA concentrations and GDM risk, and may act as a confounder or an effect modifier of the association. Methods We included 350 term births from the Lifecodes pregnancy cohort (Boston, MA), who had 1st and 2nd trimester measures of urinary BPA concentrations available. BPA measures were SG-adjusted and categorized into quartiles (Q). Multivariable-adjusted linear regressions were used to determine the association between BPA, at both 1st and 2nd trimester, and glucose, in the overall population and by categories of 1st trimester BMI. Results No clear associations were seen between BPA and glucose levels in the overall population. From stratified analyses there was suggestive evidence of effect modification by maternal 1st trimester BMI, with significant associations observed among obese/overweight participants (1st trimester BPA concentrations for Q3 vs Q1: adj.β = 14.1 mg/dL; 95% CI: 1.5, 26.6) (2nd trimester BPA concentrations for Q2 vs Q1: adj. β = 16.9 mg/dL; 95% CI: 2.6, 31.2). Conclusion No associations were found between BPA and glucose levels in the overall population. However, moderately high BPA concentrations were associated with increased glucose levels among overweight/obese women—a subgroup at high-risk of elevated glucose levels in pregnancy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Distribution and predictors of urinary polycyclic aromatic hydrocarbon metabolites in two pregnancy cohort studies.
- Author
-
Cathey, Amber, Ferguson, Kelly K., McElrath, Thomas F., Cantonwine, David E., Pace, Gerry, Alshawabkeh, Akram, Cordero, Jose F., and Meeker, John D.
- Subjects
POLYCYCLIC aromatic hydrocarbons & the environment ,ENVIRONMENTAL exposure ,PREGNANCY complications ,URINALYSIS - Abstract
Pregnant women and their fetuses represent susceptible populations to environmental contaminants. Exposure to polycyclic aromatic hydrocarbons (PAHs) among pregnant women may contribute to adverse birth outcomes such as preterm birth. Multiple previous studies have assessed airborne sources of PAHs among pregnant women but few have measured urinary PAH metabolites which can capture total exposure through multiple routes. The aim of this study was to bridge this knowledge gap by assessing longitudinal urinary PAH metabolite concentrations over two time points in pregnancy cohorts in Boston (N = 200) and Puerto Rico (N = 50) to better understand exposure distributions throughout pregnancy and how they relate to demographic factors. Urine samples were analyzed for 1-NAP, 2-NAP, 2-FLU, 1-PHE, 2,3-PHE, 4-PHE, 9-PHE, and 1-PYR. Concentrations of 2-NAP, 1-PYR, and 4-PHE were higher in Puerto Rico, while all other metabolites were present in higher concentrations in Boston. In Puerto Rico, intraclass correlation coefficients (ICC) were weak to moderate, ranging from 0.06 to 0.42. PAH metabolite concentrations were significantly higher among younger, heavier (except 1-NAP and 9-PHE), and less educated individuals in Boston only. Consistent significant associations between PAH concentrations and measured covariates were not found in Puerto Rico. Our results suggest that potentially important differences in PAH exposure exist between these two populations. Additionally, our results indicate that multiple urinary measurements are required to accurately assess PAH exposure throughout pregnancy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Fetal growth trajectories of babies born large-for-gestational age in the LIFECODES Fetal Growth Study.
- Author
-
Bommarito, Paige A., Cantonwine, David E., Stevens, Danielle R., Welch, Barrett M., Davalos, Angel D., Zhao, Shanshan, McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
FETAL development ,GESTATIONAL age ,NEONATAL intensive care units ,BIRTH injuries - Abstract
Background: Babies born large-for-gestational age have an increased risk of adverse health outcomes, including birth injuries, childhood obesity, and cardiometabolic disorders. However, little work has been done to characterize patterns of fetal growth among large-for-gestational age births, which may further elucidate high- and low-risk subgroups.Objective: This study aimed to identify subgroups of large-for-gestational age births based on trajectories of fetal growth derived from prenatal ultrasound measurements and explore differences in sociodemographic, pregnancy, and birth outcome characteristics across subgroups.Study Design: This study identified and described trajectories of fetal growth among large-for-gestational age births (n=235) in the LIFECODES Fetal Growth Study. Ultrasound measurements of fetal growth in middle to late pregnancy were abstracted from health records. Group-based multi-trajectory modeling was applied to measurements of head circumference, abdominal circumference, and femur length z-scores to identify multivariate trajectories of fetal growth. Moreover, sociodemographic variables, pregnancy characteristics, and birth outcomes based on trajectory membership were summarized.Results: This study identified 4 multivariate trajectories of fetal growth among large-for-gestational age births: catch-up growth (n=28), proportional abdominal circumference-to-femur length growth (n=67), disproportional abdominal circumference-to-femur length growth (n=96), and consistently large (n=44). Fetuses in the "catch-up growth" group exhibited small relative sizes in midpregnancy (ie, below average head circumference, abdominal circumference, and femur length z-scores) and large relative sizes in late pregnancy. Growth among these births was driven by increases in relative abdominal circumference and head circumference sizes. Participants who delivered births assigned to this group were less likely to have normal glucose control (40% vs 65%-75%) and more likely to have pregestational diabetes mellitus (36% vs 10%-17%) than other large-for-gestational age subgroups. In addition, the babies in this trajectory group were more likely to have macrosomia (86% vs 67%-73%) and to be admitted to the neonatal intensive care unit (32% vs 14%-21%) than other large-for-gestational age subgroups. In contrast, babies in the "consistently large" group had the largest relative size for all growth parameters throughout gestation and experienced a lower risk of adverse birth outcomes than other large-for-gestational age subgroups.Conclusion: This study characterized several trajectories of fetal growth among large-for-gestational age births, which were related to different pregnancy characteristics and the distribution of adverse birth outcomes. Although the number of individuals within some trajectories was small, a subgroup that exhibited a catch-up growth phenotype during gestation was identified, which may be uniquely associated with exposure to pregestational diabetes mellitus and a higher risk of admission to the neonatal intensive care unit. These results have highlighted that the risk of adverse outcomes may not be evenly distributed across all large-for-gestational age births. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
11. An application of group-based trajectory modeling to define fetal growth phenotypes among small-for-gestational-age births in the LIFECODES Fetal Growth Study.
- Author
-
Bommarito, Paige A., Cantonwine, David E., Stevens, Danielle R., Welch, Barrett M., Davalos, Angel D., Zhao, Shanshan, McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
FETAL development ,FETAL growth retardation ,SMALL for gestational age ,NEONATAL intensive care units ,FETAL ultrasonic imaging - Abstract
Reductions in fetal growth are associated with adverse outcomes at birth and later in life. However, identifying fetuses with pathologically small growth remains challenging. Definitions of small-for-gestational age are often used as a proxy to identify those experiencing pathologic growth (ie, fetal growth restriction). However, this approach is subject to limitation as most newborns labeled small-for-gestational age are constitutionally, not pathologically, small. Incorporating repeated ultrasound measures to examine fetal growth trajectories may help distinguish pathologic deviations in growth from normal variability, beyond a simple definition of small-for-gestational age. This study aimed to characterize phenotypes of growth using ultrasound trajectories of fetal growth among small-for-gestational-age births. This study identified and described trajectories of fetal growth among small-for-gestational-age births (<10th percentile weight for gestational age; n=245) in the LIFECODES Fetal Growth Study using univariate and multivariate trajectory modeling approaches. Available ultrasound measures of fetal growth (estimated fetal weight, head circumference, abdominal circumference, and femur length) from health records were abstracted. First, univariate group-based trajectory modeling was used to define trajectories of estimated fetal weight z scores during gestation. Second, group-based multi-trajectory modeling was used to identify trajectories based on concurrent measures of head circumference, abdominal circumference, and femur length z scores. Last, how these trajectories were related to patient demographics, pregnancy characteristics, and birth outcomes compared with those observed among appropriate-for-gestational-age controls was described. Of note, 3 univariate trajectories of estimated fetal weight and 4 multivariate trajectories of fetal growth among small-for-gestational-age births were identified. In our univariate approach, infants with the smallest estimated fetal weight trajectory throughout pregnancy had poorer outcomes, including the highest risk of neonatal intensive care unit admission. The remaining univariate trajectory groups did not have an elevated risk of adverse birth outcomes relative to appropriate-for-gestational-age controls. In our multivariate approach, 2 groups at increased or moderately increased risk of neonatal intensive care unit admission were identified, including infants that remained extremely small for all parameters throughout pregnancy and those who had disproportionately smaller femur length and abdominal circumference compared with head circumference. The remaining multivariate trajectory groups did not have an elevated risk of adverse birth outcome relative to appropriate-for-gestational-age controls. Latent class group-based trajectory modeling applied to ultrasound measures of fetal growth may help distinguish pathologic vs constitutional growth profiles among newborns born small-for-gestational age. Although trajectories cannot be fully characterized until delivery, limiting the direct clinical application of these methods, they may still contribute to the development of approaches for separating growth restriction from constitutional smallness. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Repeated measures analysis of associations between urinary bisphenol-A concentrations and biomarkers of inflammation and oxidative stress in pregnancy.
- Author
-
Ferguson, Kelly K., Cantonwine, David E., McElrath, Thomas F., Mukherjee, Bhramar, and Meeker, John D.
- Subjects
- *
BISPHENOL A , *INFLAMMATION , *OXIDATIVE stress , *PREGNANCY , *BODY mass index , *CYTOKINES - Abstract
Bisphenol-A (BPA) exposure occurs commonly and may adversely impact pregnancy. Endocrine disruption is posited as the primary mechanism of action, but oxidative stress and inflammation pathways may also be important. We investigated associations between BPA exposure and oxidative stress and inflammation in 482 pregnant women. Participants were recruited early in pregnancy and provided urine and plasma at up to four visits. We measured total BPA and two biomarkers of oxidative stress (8-hydroxydeoxyguanosine and 8-isoprostane) in urine from each visit. Inflammation markers, including C-reactive protein and four cytokines were measured in plasma from the same time points. In adjusted models, an interquartile range increase in BPA was associated with significant increases in both oxidative stress biomarkers (5–9% increase). Additionally, we observed significantly higher IL-6 concentrations in association with an interquartile range increase in BPA (8.95% increase). These systemic changes consequent to BPA exposure may mediate adverse birth outcomes and/or fetal development. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. Circulating microparticle proteins predict pregnancies complicated by placenta accreta spectrum.
- Author
-
Yu, Hope Y., Cantonwine, David E., Carusi, Daniela A., Gurnani, Prem, Rosenblatt, Kevin P., and McElrath, Thomas F.
- Subjects
PLACENTA accreta ,PREGNANCY proteins - Published
- 2022
- Full Text
- View/download PDF
14. Distribution and determinants of urinary biomarkers of exposure to organophosphate insecticides in Puerto Rican pregnant women.
- Author
-
Lewis, Ryan C., Cantonwine, David E., Anzalota Del Toro, Liza V., Calafat, Antonia M., Valentin-Blasini, Liza, Davis, Mark D., Montesano, M. Angela, Alshawabkeh, Akram N., Cordero, José F., and Meeker, John D.
- Subjects
- *
MATERNAL health , *CHOLINESTERASE reactivators , *BIOMARKERS , *INSECTICIDES , *ACQUISITION of data , *MALATHION - Abstract
Globally, human exposures to organophosphate (OP) insecticides may pose a significant burden to the health of mothers and their developing fetuses. Unfortunately, relevant data is limited in certain areas of the world concerning sources of exposure to OP insecticides in pregnant populations. To begin to address this gap in information for Puerto Rico, we studied repeated measures of urinary concentrations of 10 OP insecticide metabolites among 54 pregnant women from the northern karst region of the island. We also collected demographic data and self-reported information on the consumption of fruits, vegetables, and legumes in the past 48 h before urine collection and home pest-related issues. We calculated the distributions of the urinary biomarkers and compared them to women of reproductive age from the general U.S. population. We also used statistical models accounting for correlated data to assess within-subject temporal variability of the urinary biomarkers and to identify predictors of exposure. We found that for all but two metabolites ( para -nitrophenol [PNP], diethylthiophosphate [DETP]), 50th or 95th percentile urinary concentrations (the metric that was used for comparison was based on the biomarker's detection frequency) of the other eight metabolites (3,5,6-trichloro-2-pyridinol [TCPY], 2-isopropyl-4-methyl-6-hydroxy-pyrimidine, malathion dicarboxylic acid, diethylphosphate, diethyldithiophosphate, dimethylphosphate, dimethylthiophosphate [DMTP], dimethyldithiophosphate) were somewhat lower in our cohort compared with similarly aged women from the continental United States. TCPY, PNP, DETP, and DMTP, which were the only urinary metabolites detected in greater than 50% of the samples, had poor reproducibility (intraclass correlation coefficient range: 0.19–0.28) during pregnancy. Positive predictors of OP insecticide exposure included: age; marital or employment status; consumption of cherries, grape juice, peanuts, peanut butter, or raisins; and residential application of pesticides. Further research is needed to understand what aspects of the predictors identified influence OP insecticide exposure during pregnancy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
15. Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: Distribution, temporal variability, and predictors.
- Author
-
Cantonwine, David E., Cordero, José F., Rivera-González, Luis O., Anzalota Del Toro, Liza V., Ferguson, Kelly K., Mukherjee, Bhramar, Calafat, Antonia M., Crespo, Noe, Jiménez-Vélez, Braulio, Padilla, Ingrid Y., Alshawabkeh, Akram N., and Meeker, John D.
- Subjects
- *
PHTHALATE esters , *METABOLITES , *MATERNAL health , *DISEASE prevalence , *URINALYSIS - Abstract
Background: Phthalate contamination exists in the North Coast karst aquifer system in Puerto Rico. In light of potential health impacts associated with phthalate exposure, targeted action for elimination of exposure sources may be warranted, especially for sensitive populations such as pregnant women. However, information on exposure to phthalates from a variety of sources in Puerto Rico is lacking. The objective of this study was to determine concentrations and predictors of urinary phthalate biomarkers measured at multiple times during pregnancy among women living in the Northern karst area of Puerto Rico. Methods: We recruited 139 pregnant women in Northern Puerto Rico and collected urine samples and questionnaire data at three separate visits (18±2weeks, 22±2weeks, and 26±2weeks of gestation). Urine samples were analyzed for eleven phthalate metabolites: mono-2-ethylhexyl phthalate (MEHP), mono-2-ethyl-5-hydroxyhexyl phthalate, mono-2-ethyl-5-oxohexyl phthalate, mono-2-ethyl-5-carboxypentyl phthalate, mono-ethyl phthalate (MEP), mono-n-butyl phthalate, mono-benzyl phthalate, mono-isobutyl phthalate, mono-3-carboxypropyl phthalate (MCPP), mono carboxyisononyl phthalate (MCNP), and mono carboxyisooctyl phthalate (MCOP). Results: Detectable concentrations of phthalate metabolites among pregnant women living in Puerto Rico was prevalent, and metabolite concentrations tended to be higher than or similar to those measured in women of reproductive age from the general US population. Intraclass correlation coefficients ranged from very weak (MCNP; 0.05) to moderate (MEP; 0.44) reproducibility among all phthalate metabolites. We observed significant or suggestive positive associations between urinary phthalate metabolite concentrations and water usage/storage habits (MEP, MCNP, MCOP), use of personal care products (MEP), and consumption of certain food items (MCPP, MCNP, and MCOP). Conclusions: To our knowledge this is the first study to report concentrations, temporal variability, and predictors of phthalate biomarkers among pregnant women in Puerto Rico. Preliminary results suggest several potentially important exposure sources to phthalates in this population and future analysis from this ongoing prospective cohort will help to inform targeted approaches to reduce exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
16. 1029 Indications for toxicology testing: does race matter?
- Author
-
Perlman, Nicola, Cantonwine, David E., and Smith, Nicole
- Subjects
TOXICITY testing ,PREMATURE rupture of fetal membranes - Published
- 2021
- Full Text
- View/download PDF
17. 1216: Critically short telomeres are increased in human gestational tissue compared to fetal cord blood.
- Author
-
Edelson, Paula K., Sawyer, Michala, Lee, Jasmine, Gray, Kathryn J., Cantonwine, David E., McElrath, Thomas F., and Phillippe, Mark
- Subjects
CORD blood ,TELOMERES ,FETAL tissues - Published
- 2020
- Full Text
- View/download PDF
18. Circulating microparticle proteins obtained in the late first trimester predict spontaneous preterm birth at less than 35 weeks' gestation: a panel validation with specific characterization by parity.
- Author
-
McElrath, Thomas F., Cantonwine, David E., Jeyabalan, Arun, Doss, Robert C., Page, Gail, Roberts, James M., Brohman, Brian, Zhang, Zhen, and Rosenblatt, Kevin P.
- Subjects
PREMATURE labor ,PROTEOMICS ,PREGNANCY ,RECEIVER operating characteristic curves ,ETHYLENEDIAMINETETRAACETIC acid - Abstract
Background: We have previously shown that protein biomarkers associated with circulating microparticles proteins (CMPs) obtained at the end of the first trimester may detect physiologic changes in maternal-fetal interaction such that the risk of spontaneous preterm delivery ≤35 weeks can be stratified.Objectives: We present here a study extension and validation of the CMP protein multiplex concept using a larger sample set from a multicenter population that allows for model derivation in a training set and characterization in a separate testing set.Materials and Methods: Ethylenediaminetetraacetic acid (EDTA) plasma was obtained from 3 established biobanks (Seattle, Boston, and Pittsburgh). Samples were from patients at a median of 10-12 weeks' gestation, and the CMPs were isolated via size-exclusion chromatography followed by protein identification via targeted protein analysis using liquid chromatography-multiple reaction monitoring-mass (LC-MRM) spectrometry. A total of 87 women delivered at ≤35 weeks, and 174 women who delivered at term were matched by maternal age (±2 years) and gestational age at sample draw (±2 weeks). From our prior work, the CMP protein multiplex comprising F13A, FBLN1, IC1, ITIH2, and LCAT was selected for validation.Results: For delivery at ≤35 weeks, the receiver operating characteristic (ROC) curve for a panel of CMP proteins (F13A, FBLN1, IC1, ITIH2, and LCAT) revealed an associated area under the ROC curve (AUC) of 0.74 (95% CI, 0.63-0.81). A separate panel of markers (IC1, LCAT, TRFE, and ITIH4), which stratified risk among mothers with a parity of 0, showed an AUC of 0.77 (95% CI, 0.61-0.90).Conclusion: We have identified a set of CMP proteins that provide, at 10-12 weeks gestation, a clinically useful AUC in an independent test population. Furthermore, we determined that parity is pertinent to the diagnostic testing performance of the biomarkers for risk stratification. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
19. 708: Extracellular vesicle proteomic markers obtained at 24-28 weeks stratify the risk of spontaneous preterm birth to <35 weeks gestation.
- Author
-
Cantonwine, David E., Rosenblatt, Kevin, Doss, Robert C., Page, Gail, Brohman, Brian, and McElrath, Thomas F.
- Published
- 2018
- Full Text
- View/download PDF
20. 616: Comparison of circulating extracellular vesicle versus plasma proteins for prediction of spontaneous preterm birth.
- Author
-
Cantonwine, David E., Rosenblatt, Kevin, Doss, Robert C., Page, Gail, Brohman, Brian, and McElrath, Thomas F.
- Published
- 2018
- Full Text
- View/download PDF
21. 764: Longitudinal comparison of circulating microparticle proteomics for prediction of spontaneous preterm birth between first and second trimester.
- Author
-
Lassey, Sarah C., Cantonwine, David E., Rosenblatt, Kevin, Doss, Robert C., Page, Gail, Brohman, Brian, and McElrath, Thomas F.
- Published
- 2018
- Full Text
- View/download PDF
22. 631: The human urinary metabolome changes dramatically across gestation.
- Author
-
Gray, Kathryn J., Avila-Pacheco, Julian, Cantonwine, David E., McElrath, Thomas F., Clish, Clary B., and Saxena, Richa
- Published
- 2018
- Full Text
- View/download PDF
23. 14: Extracellular vesicle proteomic markers obtained at 12 weeks predict spontaneous preterm birth less than 35 weeks gestation: a validation with specific characterization of marker behavior by fetal gender and parity.
- Author
-
McElrath, Thomas, Cantonwine, David E., Jeyabalan, Arun, Doss, Robert, Page, Gail, Roberts, James M., Brohman, Brian, and Rosenblatt, Kevin P.
- Published
- 2018
- Full Text
- View/download PDF
24. Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.
- Author
-
Ferguson, Kelly K., Meeker, John D., McElrath, Thomas F., Mukherjee, Bhramar, and Cantonwine, David E.
- Subjects
OXIDATIVE stress ,BIOMARKERS ,PREECLAMPSIA ,INFLAMMATION ,ISOPROSTANES ,C-reactive protein ,COMPARATIVE studies ,CYTOKINES ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,PROSTAGLANDINS ,RESEARCH ,RESEARCH funding ,EVALUATION research ,PROPORTIONAL hazards models ,DEOXYRIBONUCLEOSIDES - Abstract
Background: Preeclampsia is a prevalent and enigmatic disease, in part characterized by poor remodeling of the spiral arteries. However, preeclampsia does not always clinically present when remodeling has failed to occur. Hypotheses surrounding the "second hit" that is necessary for the clinical presentation of the disease focus on maternal inflammation and oxidative stress. Yet, the studies to date that have investigated these factors have used cross-sectional study designs or small study populations.Objective: In the present study, we sought to explore longitudinal trajectories, beginning early in gestation, of a panel of inflammation and oxidative stress markers in women who went on to have preeclamptic or normotensive pregnancies.Study Design: We examined 441 subjects from the ongoing LIFECODES prospective birth cohort, which included 50 mothers who experienced preeclampsia and 391 mothers with normotensive pregnancies. Participants provided urine and plasma samples at 4 time points during gestation (median, 10, 18, 26, and 35 weeks) that were analyzed for a panel of oxidative stress and inflammation markers. Oxidative stress biomarkers included 8-isoprostane and 8-hydroxydeoxyguanosine. Inflammation biomarkers included C-reactive protein, the cytokines interleukin-1β, -6, and -10, and tumor necrosis factor-α. We created Cox proportional hazard models to calculate hazard ratios based on time of preeclampsia diagnosis in association with biomarker concentrations at each of the 4 study visits.Results: In adjusted models, hazard ratios of preeclampsia were significantly (P<.01) elevated in association with all inflammation biomarkers that were measured at visit 2 (median, 18 weeks; hazard ratios, 1.31-1.83, in association with an interquartile range increase in biomarker). Hazard ratios at this time point were the most elevated for C-reactive protein, for interleukin-1β, -6, and -10, and for the oxidative stress biomarker 8-isoprostane (hazard ratio, 1.68; 95% confidence interval, 1.14-2.48) compared to other time points. Hazard ratios for tumor necrosis factor-α were consistently elevated at all 4 of the study visits (hazard ratios, 1.49-1.63; P<.01). In sensitivity analyses, we observed that these associations were attenuated within groups typically at higher risk of experiencing preeclampsia, which include African American mothers, mothers with higher body mass index at the beginning of gestation, and pregnancies that ended preterm.Conclusions: This study provides the most robust data to date on repeated measures of inflammation and oxidative stress in preeclamptic compared with normotensive pregnancies. Within these groups, inflammation and oxidative stress biomarkers show different patterns across gestation, beginning as early as 10 weeks. The start of the second trimester appears to be a particularly important time point for the measurement of these biomarkers. Although biomarkers alone do not appear to be useful in the prediction of preeclampsia, these data are useful in understanding the maternal inflammatory profile in pregnancy before the development of the disease and may be used to further develop an understanding of potentially preventative measures. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
25. 891: Angle of progression and its association with mode of delivery and duration of the second stage.
- Author
-
Bibbo, Carolina, Rouse, Caroline E., Cantonwine, David E., McElrath, Thomas F., and Robinson, Julian N.
- Subjects
SECOND trimester of pregnancy ,DELIVERY (Obstetrics) ,ULTRASONIC imaging ,SURVIVAL analysis (Biometry) ,LOGISTIC regression analysis - Published
- 2017
- Full Text
- View/download PDF
26. Associations between maternal plasma measurements of inflammatory markers and urinary levels of phenols and parabens during pregnancy: A repeated measures study.
- Author
-
Aung, Max T., Ferguson, Kelly K., Cantonwine, David E., Bakulski, Kelly M., Mukherjee, Bhramar, Loch-Caruso, Rita, McElrath, Thomas F., and Meeker, John D.
- Abstract
Abstract Background Maternal immune system regulation is critical for maintenance of a healthy pregnancy and fetal development. Exposure to phenols and parabens is widespread, and may be linked to systemic inflammation and alteration of circulating immunological biomarkers. Objective We sought to characterize associations between repeated measures of individual urinary phenols, parabens and plasma inflammatory markers across pregnancy. Methods In the LIFECODES prospective birth cohort, we conducted a nested preterm birth case-control study, including 130 cases and 352 controls. In urine samples collected from each participant at up to four study visits during pregnancy, we measured concentrations of six phenols and four parabens, as well as five plasma inflammatory markers. We used multivariable linear mixed models to analyze repeated measures of exposures on inflammatory markers. We created and applied inverse probability weights to account for the sampling approach. Results We observed bidirectional associations between select phenols and parabens and inflammatory markers. An interquartile range increase in triclosan (55.2 ng/mL) was associated with a 12.5% (95% CI: 3.67, 22.0) increase in C-reactive protein, a 7.95% (95% CI: 1.95, 14.3) increase in interleukin 10, and a 7.93% (95% CI: 3.82, 12,2) increase in tumor necrosis factor-α. Additionally, an interquartile range increase in 2,5-dichlorophenol (11.0 ng/mL) was associated with a 10% increase in C-reactive protein (95% CI: 1.92, 18.7). Conversely, an interquartile range increase in ethyl paraben (10.4 ng/mL) was associated with a 7.7% decrease in interleukin‑1β (95% CI: −14.1, −0.86). Conclusions Our findings can be organized into two thematic frameworks, one where concentrations of urinary phenols and parabens during pregnancy reflected a pro-inflammatory relationship with immunological biomarkers, and the other contrary theme – an anti-inflammatory relationship. These findings have implications for fetal development and reproductive outcomes, and emphasize the need for further research on immunological mechanisms of phenol and paraben action during pregnancy. Graphical abstract Unlabelled Image Highlights • Phenol exposure during pregnancy was associated with systemic plasma immune biomarkers. • 2,5-Dichlorophenol and triclosan were positively associated with C-reactive protein. • Triclosan was positively associated with tumor necrosis factor-α and interleukin-10. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
27. The association of early unexplained elevated alanine aminotransferase with large-for-gestational-age birthweight.
- Author
-
Yarrington, Christina D., Cantonwine, David E., Seely, Ellen W., Mcelrath, Thomas F., and Zera, Chloe A.
- Subjects
ALANINE aminotransferase ,BIRTH weight ,FATTY liver ,INSULIN resistance ,METABOLIC syndrome ,GESTATIONAL age ,GLUCOSE tolerance tests ,FIRST trimester of pregnancy ,CASE-control method ,FETAL macrosomia ,ODDS ratio - Abstract
Background: Nonalcoholic fatty liver disease causes hepatic insulin resistance and is associated with metabolic syndrome. Elevated levels of alanine aminotransferase are associated with nonalcoholic fatty liver disease. The effect of hepatic insulin resistance is not only increased glycogen breakdown but also liberation of free fatty acids due to increased lipolysis. Both of these fuel sources are associated with macrosomia. There is little known about the impact of maternal nonalcoholic fatty liver disease on excessive fetal growth.Objective: The purpose of this study was to investigate the association of early elevated alanine aminotransferase with large-for-gestational-age birthweight.Study Design: This is a secondary analysis from a nested case-control study of maternal alanine aminotransferase values measured between 8-18 weeks and subsequent gestational diabetes. We included women with singleton gestations with complete delivery information and without known diabetes, liver disease, or moderate self-reported alcohol use during pregnancy. We used inverse probability weighting to standardize the population and minimize selection bias. We calculated population-based birthweight z scores and defined large for gestational age as ≥90th percentile for gestational age. We compared maternal baseline characteristics with analysis of variance, Fisher exact test, or Wilcoxon rank sum. We then performed conditional logistic regression to evaluate the relationship between alanine aminotransferase and large for gestational age adjusting for maternal age, body mass index, parity, gestational diabetes, smoking, and maternal weight gain.Results: We identified 26 cases of large for gestational age out of 323 mother-infant dyads. The mean maternal body mass index was higher in the large-for-gestational-age group compared to controls (33.7 [SD 4.3] vs 28.9 [SD 6.5], P = .002). Large-for-gestational-age babies were less likely to be male (8 [31%] vs 172 [58%], P = .01) and had a higher mean gestational age (39.5 [SD 0.9] vs 38.4 [SD 2.3] weeks, P = .01). Maternal and infant characteristics were otherwise similar. The mean alanine aminotransferase among the large-for-gestational-age cases was 28 (SD 37) U/L compared to 16 (SD 8) U/L for controls. Each unit increase in log-transformed alanine aminotransferase was associated with a 3-fold odds of large for gestational age (adjusted odds ratio, 3.05; 95% confidence interval, 2.27-4.10; P < .0001), and alanine aminotransferase ≥90th percentile (26 U/L) was associated with a 4-fold increased odds of large for gestational age (adjusted odds ratio, 4.03; 95% confidence interval, 2.84-5.70; P < .0001). This association was unchanged when analysis was restricted only to women without gestational diabetes with a glucose loading test <120 mg/dL (log-transformed alanine aminotransferase: adjusted odds ratio, 3.05; 95% confidence interval, 1.04-8.96; P = .04, and alanine aminotransferase ≥90th percentile: adjusted odds ratio, 4.21; 95% confidence interval, 1.20-14.82; P = .03).Conclusion: Unexplained elevated alanine aminotransferase in the first trimester was associated with a 4-fold increase in the odds of large-for-gestational-age birthweight even in the absence of clinical glucose intolerance. This may represent the impact of maternal nonalcoholic fatty liver on the fetal developmental milieu. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
28. Evaluation of proteomic biomarkers associated with circulating microparticles as an effective means to stratify the risk of spontaneous preterm birth.
- Author
-
Cantonwine, David E., Zhang, Zhen, Rosenblatt, Kevin, Goudy, Kevin S., Doss, Robert C., Ezrin, Alan M., Page, Gail, Brohman, Brian, and McElrath, Thomas F.
- Subjects
PROTEOMICS ,BIOMARKERS ,PREMATURE labor ,RISK factors in premature labor ,GESTATIONAL age ,MASS spectrometry ,DIAGNOSIS ,CELL membranes ,PREMATURE infants ,LIQUID chromatography ,LONGITUDINAL method ,FIRST trimester of pregnancy ,RESEARCH funding ,RISK assessment ,CASE-control method ,RECEIVER operating characteristic curves - Abstract
Background: The analysis of circulating microparticles in pregnancy is of revolutionary potential because it represents an in vivo biopsy of active gestational tissues.Objective: We hypothesized that circulating microparticle signaling will differ in pregnancies that experience spontaneous preterm birth from those delivering at term and that these differences will be evident many weeks in advance of clinical presentation.Study Design: Utilizing plasma specimens obtained between 10 and 12 weeks' gestation as part of a prospectively collected birth cohort in which pregnancy outcomes are independently validated by 2 board-certified maternal-fetal medicine physicians, 25 singleton cases of spontaneous preterm birth ≤ 34 weeks were matched by maternal age, race, and gestational age of sampling (±2 weeks) with 50 uncomplicated term deliveries. Circulating microparticles from these first-trimester specimens were isolated and analyzed by multiple reaction monitoring mass spectrometry for potential protein biomarkers following previous studies. Markers with robust univariate performance in correlating spontaneous preterm birth were further evaluated for their biological relevance via a combined functional profiling/pathway analysis and for multivariate performance.Results: Among the 132 proteins evaluated, 62 demonstrated robust power of detecting spontaneous preterm birth in a bootstrap receiver-operating characteristic curve analysis at a false discovery rate of < 20% estimated via label permutation. Differential dependency network analysis identified spontaneous preterm birth-associated coexpression patterns linked to biological processes of inflammation, wound healing, and the coagulation cascade. Linear modeling of spontaneous preterm birth using a multiplex of the candidate biomarkers with a fixed sensitivity of 80% exhibited a specificity of 83% with median area under the curve of 0.89. These results indicate a strong potential of multivariate model development for informative risk stratification.Conclusion: This project has identified functional proteomic factors with associated biological processes that are already unique in their expression profiles at 10-12 weeks among women who go on to deliver spontaneously ≤ 34 weeks. These changes, with further validation, will allow the stratification of patients at risk of spontaneous preterm birth before clinical presentation. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
29. Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia.
- Author
-
Easter, Sarah Rae, Cantonwine, David E., Zera, Chloe A., Lim, Kee-Hak, Parry, Samuel I., and McElrath, Thomas F.
- Subjects
URINARY tract infections ,VASCULAR endothelial growth factors ,RISK factors of preeclampsia ,BIOMARKERS ,PATHOLOGICAL physiology ,PREGNANCY complications - Abstract
Background: Despite decades of research, and much progress in discernment of biomarkers in the maternal circulation, the pathogenesis of preeclampsia (PE) remains elusive. The pathophysiology of PE is believed to involve aberrant placentation and an associated increase in systemic inflammation. In this conceptualization, PE becomes more likely when the level of systemic inflammatory burden inherent in pregnancy itself exceeds the maternal capacity to compensate for this additional stress. If this is the case, then it is possible to hypothesize that conditions, such as infectious disease, that increase systemic inflammatory burden should also increase the risk of PE. As urinary tract infection (UTI) represents a common source of inflammation during pregnancy, we tested whether presence of UTI during pregnancy increased the odds of developing PE. Prior work has documented this association. However many of these studies were limited by small cohort sizes and insufficient control for covariates.Objective: The present study is a secondary analysis of a robust contemporary obstetrical cohort recruited to examine the ability of longitudinally sampled maternal angiogenic concentrations to predict PE. We hypothesize that the occurrence of UTI during a pregnancy is associated with the later occurrence of PE in that pregnancy. As PE is believed to be associated with aberrations in systemic angiogenic levels (placental growth factor and soluble isoform of VEGF receptor), we further hypothesize that there will be significant interactions between maternal angiogenic protein levels and the occurrence of UTI.Study Design: Women aged ≥18 years (n = 2607) were recruited and followed up prospectively from the initiation of prenatal care through delivery at 3 regional academic centers. PE was defined by American Congress of Obstetricians and Gynecologists criteria and was independently validated by a panel of physicians. UTI was defined by the presence of clinical symptoms necessitating treatment in addition to supportive laboratory evidence. Multivariate logistic regression models were used and controlled for maternal age, race, parity, body mass index, hypertension, diabetes, in vitro fertilization, and smoking status.Results: There were 129 women with diagnosed UTIs and 235 with PE. Patients with UTI in pregnancy had higher rates of PE (31.1% vs 7.8%, P < .001) compared to those without reported UTI. The mean gestational age (SD) for UTI diagnosis in PE cases and controls was 25.6 (10.4) and 21.9 (10.9) weeks, respectively (P = .08). The unadjusted odds ratio for PE in the setting of UTI was 5.29 (95% confidence interval, 3.54-7.89). After controlling for confounders, UTI was associated with an odds ratio for PE of 3.2 (95% confidence interval, 2.0-5.1).Conclusion: Presence of UTI in pregnancy, particularly in the third trimester, is strongly associated with PE. This association supports the hypothesis that the risk of PE is enhanced by an increased maternal inflammatory burden. Prophylaxis against UTI represents a potentially low-cost global intervention to slow or halt the development of PE. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
30. 751: Urinary phthalates increase PAPP-A levels early in pregnancy.
- Author
-
Cantonwine, David E., Meeker, John D., Ferguson, Kelly K., Wilkins-Haug, Louise E., Lambert-Messerlian, Geralyn, and McElrath, Thomas F.
- Subjects
CHORIONIC gonadotropins ,BLOOD proteins ,BIOMARKERS ,ENDOCRINE disruptors ,LONGITUDINAL method ,COHORT analysis - Published
- 2016
- Full Text
- View/download PDF
31. 19: Circulating microparticles as an effective means to stratify the risk of spontaneous preterm birth.
- Author
-
Cantonwine, David E., Zhang, Zhen, Goudy, Kevin S., Brohman, Brian D., Ezrin, Alan M., Doss, Robert C., Page, Gail S., Jiang, Qi, Escher, Claudia, and McElrath, Thomas F.
- Subjects
RISK factors in premature labor ,VESICLES (Cytology) ,BIOPSY ,GESTATIONAL age ,DELIVERY (Obstetrics) ,OBSTETRICS ,GYNECOLOGY - Published
- 2016
- Full Text
- View/download PDF
32. 602: An unappreciated cause of prematurity: delivery defined by medical protocol.
- Author
-
Rouse, Caroline, Cantonwine, David E., Thomas, Ann, and McElrath, Thomas F.
- Subjects
PREMATURE aging (Medicine) ,ETIOLOGY of diseases ,DELIVERY (Obstetrics) ,GYNECOLOGY ,MEDICAL research - Published
- 2016
- Full Text
- View/download PDF
33. 816: Inflammatory and oxidative stress markers associated with decreased cervical length in pregnancy.
- Author
-
Venkatesh, Kartik K., Cantonwine, David E., Ferguson, Kelly, Arjona, Melanie, Meeker, John, and McElrath, Thomas F.
- Subjects
OXIDATIVE stress ,BIOMARKERS ,PREGNANCY ,INFLAMMATION ,MEDICAL research - Published
- 2016
- Full Text
- View/download PDF
34. 815: Is there an association between body mass index and cervical length? Implications for obesity and cervical length management in pregnancy.
- Author
-
Venkatesh, Kartik K., Cantonwine, David E., Zera, Chloe, Arjona, Melanie, Smith, Nicole A., Robinson, Julian N., and McElrath, Thomas F.
- Subjects
BODY mass index ,OBESITY ,CERVICAL vertebrae ,PREGNANCY ,DISEASE management - Published
- 2016
- Full Text
- View/download PDF
35. Environmental phenol associations with ultrasound and delivery measures of fetal growth.
- Author
-
Ferguson, Kelly K., Meeker, John D., Cantonwine, David E., Mukherjee, Bhramar, Pace, Gerry G., Weller, David, and Mcelrath, Thomas F.
- Subjects
- *
PHYSIOLOGICAL effects of phenols , *DICHLOROPHENOLS , *FETAL development , *PHENOL analysis , *PREGNANT women , *PHYSIOLOGY - Abstract
Environmental phenols are used commonly in personal care products and exposure is widespread in pregnant women. In this study, we sought to assess the association between maternal urinary phenol concentrations in pregnancy and fetal growth. The study population included 476 mothers who participated in the prospective LIFECODES birth cohort between 2006 and 2008 at Brigham and Women's Hospital in Boston, Massachusetts, USA. Dichlorophenols (DCPs), benzophenone-3, parabens, triclosan, triclocarban, and bisphenol-S were measured in urine from three time points during pregnancy and averaged. Outcome measures were all standardized to create gestational-age specific z-scores and included: 1) birth weight; 2) ultrasound parameters measured at up to two time points in pregnancy (head and abdominal circumference and femur length); and 3) ultrasound estimates of fetal weight from two time points in combination with birth weight. Models were stratified to investigate sex differences. Inverse associations were observed between average 2,4- and 2,5-DCP concentrations and birth weight z-scores in males. For example, an interquartile range difference in 2,4-DCP was associated with a 0.18 standard deviation decrease in birth weight z-score (95% confidence interval [CI] = − 0.33, − 0.02). These associations were observed in models that included repeated ultrasound estimates of fetal weight during gestation as well. Also in males, we noted inverse associations between average triclosan exposure over pregnancy and estimated fetal weight combined with birth weight in repeated measures models. For females, associations were generally null. However, mothers with a detectable concentration of bisphenol-S at any of the study visits had lower weight females. In conclusion, we observed inverse associations between indicators of maternal phenol exposure during pregnancy and fetal growth, with several differences observed by sex. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
36. Urinary phthalate metabolite concentrations in relation to levels of circulating matrix metalloproteinases in pregnant women.
- Author
-
Bedrosian, Leah D., Ferguson, Kelly K., Cantonwine, David E., Mcelrath, Thomas F., and Meeker, John D.
- Subjects
- *
PHTHALATE esters , *URINALYSIS , *METALLOPROTEINASES , *PREGNANT women , *METABOLITE analysis , *PHYSIOLOGY - Abstract
Phthalate exposure has been shown to be associated with adverse pregnancy outcomes. However, human studies informing relevant mechanistic pathways are lacking. Experimental studies have reported that matrix metalloproteinases (MMPs), which are responsible for extracellular protein degradation, may be upregulated in response to phthalate exposure. In this exploratory study we measured urinary phthalate metabolite concentrations, plasma MMP levels, and relevant covariates among 134 pregnant women. There were statistically significant or suggestive positive relationships between several phthalates, particularly between metabolites of di-(2-ethylhexyl) phthalate, with MMP-1 and MMP-9 levels. Further research is needed to confirm these results and how they may inform the mechanisms involved between phthalate exposure and adverse pregnancy outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
37. Urinary phthalate metabolite and bisphenol A associations with ultrasound and delivery indices of fetal growth.
- Author
-
Ferguson, Kelly K., Meeker, John D., Cantonwine, David E., Chen, Yin-Hsiu, Mukherjee, Bhramar, and McElrath, Thomas F.
- Subjects
- *
URINALYSIS , *METABOLITES , *BISPHENOL A , *FETAL growth disorders , *BIOMARKERS - Abstract
Growth of the fetus is highly sensitive to environmental perturbations, and disruption can lead to problems in pregnancy as well as later in life. This study investigates the relationship between maternal exposure to common plasticizers in pregnancy and fetal growth. Participants from a longitudinal birth cohort in Boston were recruited early in gestation and followed until delivery. Urine samples were collected at up to four time points and analyzed for concentrations of phthalate metabolites and bisphenol A (BPA). Ultrasound scans were performed at four time points during pregnancy for estimation of growth parameters, and birthweight was recorded at delivery. Growth measures were standardized to a larger population. For the present analysis we examined cross-sectional and repeated measures associations between exposure biomarkers and growth estimates in 482 non-anomalous singleton pregnancies. Cross-sectional associations between urinary phthalate metabolites or BPA and growth indices were imprecise. However, in repeated measures models, we observed significant inverse associations between di-2-ethylhexyl phthalate (DEHP) metabolites and estimated or actual fetal weight. An interquartile range increase in summed DEHP metabolites was associated with a 0.13 standard deviation decrease in estimated or actual fetal weight (95% confidence interval = − 0.23, − 0.03). Associations were consistent across different growth parameters (e.g., head circumference, femur length), and by fetal sex. No consistent associations were observed for other phthalate metabolites or BPA. Maternal exposure to DEHP during pregnancy was associated with decreased fetal growth, which could have repercussive effects. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
38. Prenatal exposure to environmental phenols and fetal growth across pregnancy in the LIFECODES fetal growth study.
- Author
-
Bommarito, Paige A., Stevens, Danielle R., Welch, Barrett M., Meeker, John D., Cantonwine, David E., McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
- *
FETAL development , *ENDOCRINE disruptors , *PRENATAL exposure , *FETAL ultrasonic imaging , *PHENOL , *PREGNANCY - Abstract
Environmental phenols are endocrine disrupting chemicals hypothesized to affect early life development. Previous research examining the effects of phenols on fetal growth has focused primarily on associations with measures of size at delivery. Few have included ultrasound measures to examine growth across pregnancy. Investigate associations between prenatal exposure to phenols and ultrasound and delivery measures of fetal growth. Using the LIFECODES Fetal Growth Study (n = 900), a case-cohort including 248 small-for-gestational-age, 240 large-for-gestational age, and 412 appropriate-for-gestational-age births, we estimated prenatal exposure to 12 phenols using three urine samples collected during pregnancy (median 10, 24, and 35 weeks gestation). We abstracted ultrasound and delivery measures of fetal growth from medical records. We estimated associations between pregnancy-average phenol biomarker concentrations and repeated ultrasound measures of fetal growth using linear mixed effects models and associations with birthweight using linear regression models. We also used logistic regression models to estimate associations with having a small- or large-for-gestational birth. We observed positive associations between 2,4-dichlorophenol, benzophenone-3, and triclosan (TCS) and multiple ultrasound measures of fetal growth. For example, TCS was associated with a 0.09 (95 % CI: 0.01, 0.18) higher estimated fetal weight z-score longitudinally across pregnancy. This effect size corresponds to a 21 g increase in estimated fetal weight at 30 weeks gestation. Associations with delivery measures of growth were attenuated, but TCS remained positively associated with birthweight z-scores (mean difference: 0.13, 95 % CI: 0.02, 0.25). Conversely, methylparaben was associated with higher odds of a small-for-gestational age birth (odds ratio: 1.45, 95 % CI: 1.06, 1.98). We observed associations between some biomarkers of phenol exposure and ultrasound measures of fetal growth, though associations at the time of delivery were attenuated. These findings are consistent with hypotheses that phenols have the potential to affect growth during the prenatal period. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Prenatal per- and polyfluoroalkyl substances (PFAS) and maternal oxidative stress: Evidence from the LIFECODES study.
- Author
-
Siwakoti, Ram C., Park, Seonyoung, Ferguson, Kelly K., Hao, Wei, Cantonwine, David E., Mukherjee, Bhramar, McElrath, Thomas F., and Meeker, John D.
- Subjects
- *
FLUOROALKYL compounds , *DIETARY patterns , *PREGNANCY outcomes , *WEIGHT gain , *RACE , *MATERNAL age , *OXIDATIVE stress , *PREGNANCY - Abstract
Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals linked to adverse pregnancy outcomes. Although their underlying biological mechanisms are not fully understood, evidence suggests PFAS may disrupt endocrine functions and contribute to oxidative stress (OS) and inflammation. We examined associations between early pregnancy PFAS exposure and OS biomarkers, exploring potential effect modifications by fetal sex and maternal race. We used data from 469 LIFECODES participants with measured plasma PFAS (median 10 weeks gestation) and repeated measures (median 10, 18, 26, and 35 weeks gestation) of urinary OS biomarkers [8-iso-prostaglandin-F2α (8-isoprostane) and 8-hydroxydeoxyguanosine (8-OHdG)]. Protein damage biomarkers (chlorotyrosine, dityrosine, and nitrotyrosine) were additionally measured in plasma from a subset (N = 167) during the third visit. Associations between each PFAS and OS biomarkers were examined using linear mixed-effects models and multivariable linear regressions, adjusting for potential confounders, including maternal age, race, education level, pre-pregnancy BMI, insurance status, and parity. Effect modifications were evaluated by including an interaction term between each PFAS and fetal sex or maternal race in the models. We observed significant positive associations between PFOS and 8-isoprostane, with a 9.68% increase in 8-isoprostane levels (95% CI: 0.10%, 20.18%) per interquartile range increase in PFOS. In contrast, PFUA was negatively associated [9.32% (95% CI: −17.68%, −0.11%)], while there were suggestive positive associations for MPAH and PFOA with 8-isoprostane. The associations of several PFAS with 8-OHdG varied by fetal sex, showing generally positive trends in women who delivered females, but negative or null in those who delivered males. No significant effect modification by maternal race was observed. This study provides evidence linking PFAS exposure to OS during pregnancy, with potential sex-specific effects of certain PFAS on 8-OHdG. Further research should explore additional OS/inflammatory biomarkers and assess the modifying effects of dietary and behavioral patterns across diverse populations. [Display omitted] • PFOS significantly linked with increase in 8-isoprostane levels. • MPAH and PFOA marginally linked with increase in 8-isoprostane levels. • Fetal sex-specific effects of several PFAS on 8-OHdG levels. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Prenatal urinary phthalate metabolites levels and neurodevelopment in children at two and three years of age.
- Author
-
Téllez-Rojo, Martha M., Cantoral, Alejandra, Cantonwine, David E., Schnaas, Lourdes, Peterson, Karen, Hu, Howard, and Meeker, John D.
- Subjects
- *
PHTHALATE esters , *METABOLITES , *DEVELOPMENTAL neurobiology , *URINALYSIS , *CHILD development , *PREGNANCY - Abstract
Abstract: Background: Previous studies suggest that prenatal phthalate exposure affects neurodevelopment and behavior during the first years of life. Objectives: To evaluate the effect of maternal urinary concentrations of phthalate metabolites during pregnancy on mental and psychomotor development in children 24–36months of age. Methods: This analysis was conducted on the first three years of life among a subsample of 136 mother–child pairs from the ELEMENT cohort studies conducted in Mexico City. Maternal urine samples collected during the third trimester of pregnancy were analyzed for 9 phthalate metabolites: Mono-ethyl phthalate (MEP), Mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP), mono-benzyl phthalate (MBzP), Mono-3-carboxypropyl phthalate (MCPP), and four di-2-ethylhexyl phthalate (DEHP) metabolites [mono-2-ethylhexyl-phthalate (MEHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP)]. Among the 136 children, 135 (99.3%) completed the study period. Child neurodevelopment was assessed using mental and psychomotor development indexes (MDI and PDI) from a Bayley (BSID II) test at 24, 30, and 36months of age. The effect of prenatal phthalate exposure on neurodevelopment was estimated using linear regression models for longitudinal data clustered at the individual level. Results: No significant associations were observed among all children combined, but differential effects by gender were found. Among girls, there was a negative association between MDI and DEHP metabolites MEHP (β=−2.11 [95% CI: −3.73, −0.49]), MEHHP (β=−1.89 [95% CI: −3.64, −0.15]), MEOHP (β=−1.80 [95% CI: −3.58, −0.03]) MECPP (β=−2.52 [95% CI: −4.44, −0.61]), and ΣDEHP (β=−3.41 [95% CI: −5.26, −1.55]); there was no significant effect among boys. Male PDI was positively related to MBzP (β=1.79 [95% CI: 0.14, 3.45]) and MCPP (β=1.64 [95% CI: 0.15, 3.12]); there was no significant effect on PDI among girls. Conclusion: This study demonstrates that sex plays a role of an effect modifier in the association between prenatal phthalate exposure and neurodevelopment. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
41. Manganese is associated with increased plasma interleukin-1β during pregnancy, within a mixtures analysis framework of urinary trace metals.
- Author
-
Aung, Max T., Meeker, John D., Boss, Jonathan, Bakulski, Kelly M., Mukherjee, Bhramar, Cantonwine, David E., McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
- *
TRACE metals , *MANGANESE , *PREGNANT women , *PREGNANCY , *MIXTURES - Abstract
• Multiple urinary trace metals were associated with immune biomarkers. • Manganese, barium, and nickel were positively associated with interleukin-1β. • Mixtures analysis identified manganese as most predictive of interleukin-1β. • Association between manganese and interleukin-1β was greater in women with a female fetus. Exposure to trace metals may impact reproductive health outcomes through perturbations in maternal immune signaling molecules. We conducted a cross-sectional study of 390 pregnant women from the LIFECODES birth cohort and investigated the associations between 17 urinary metals and five immune biomarkers measured in the 3rd trimester (median 26 weeks gestation). We used linear regression to estimate pair-wise associations and applied elastic net and Bayesian kernel machine regression to identify important contributing exposures analytes as well as non-linear effects. Maternal urinary manganese, nickel, and barium were positively associated with maternal plasma interleukin-1β (IL-1β). Elastic net and Bayesian kernel machine regression identified manganese as the dominant trace metal in association with IL-1β. An interquartile range difference in manganese (0.6 μg/L) was associated with a 29 % increase in IL-1β (95 % CI: 12.4–48.2). In conclusion, trace metal exposures were associated with biomarkers of immune perturbations, and this warrants further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. Early lead exposure and childhood adiposity in Mexico city.
- Author
-
Liu, Yun, Peterson, Karen E., Montgomery, Kathleen, Sánchez, Brisa N., Zhang, Zhenzhen, Afeiche, Myriam C., Cantonwine, David E., Ettinger, Adrienne S., Cantoral, Alejandra, Schnaas, Lourdes, Hu, Howard, and Teʹllez-Rojo, Martha M.
- Subjects
- *
MATERNAL exposure , *OBESITY , *WAIST circumference , *CHILDREN , *REGRESSION analysis , *BODY composition , *PUERPERIUM - Abstract
Background: Prenatal and early childhood lead exposures have been associated with reduced weight in infants and young children, while studies that have examined such associations in children during peripubescence are rare.Objectives: We investigated the associations of prenatal and early-life exposure to lead with indices of adiposity in peripubertal children living in Mexico City.Methods: Maternal bone lead (as a proxy for cumulative fetal exposure) was assessed at 1 month postpartum. Blood samples were obtained from children annually from 1 to 4 years. Multivariable linear regression models were used to examine the association between each lead biomarker and BMI z-score, waist circumference, sum of skinfolds and body fat percentage in 248 children aged 8-16 years.Results: After adjusting for covariates, maternal patella lead was associated with lower child BMI z-score (β = -0.02, 95% CI: 0.03, -0.01, p = 0.004), waist circumference (β = -0.12 cm, 95% CI: 0.22, -0.03, p = 0.01), sum of skinfolds (β = -0.29 mm, 95% CI: 0.50, -0.08, p = 0.007) and body fat percentage (β = -0.09%, 95% CI: 0.17, -0.01, p = 0.03). No significant associations were detected from the postnatal exposure period.Conclusions: We observed a significant and inverse association of prenatal lead exposure with body composition in Mexican children, suggesting the potential role of early lead exposure in the fetal programming of child growth. Further research on the biological mechanisms underlying these associations is needed. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
43. Urinary trace metals individually and in mixtures in association with preterm birth.
- Author
-
Kim, Stephani S., Meeker, John D., Carroll, Rachel, Zhao, Shanshan, Mourgas, Michael J., Richards, Michael J., Aung, Max, Cantonwine, David E., McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
- *
PREMATURE labor , *PRINCIPAL components analysis , *TRACE elements , *TRACE metals , *BIOMARKERS - Abstract
Abstract One in ten infants born in the United States is born preterm, or prior to 37 weeks gestation. Exposure to elevated levels of metals, such as lead and arsenic, has been linked to higher risk of preterm birth (PTB), but consequences of lower levels of exposure and less studied metals are unclear. We examined the associations between 17 urinary trace metals individually and in mixtures in relation to PTB. The LIFECODES birth cohort enrolled pregnant women at <15 weeks gestation at Brigham and Women's Hospital in Boston. We selected cases of PTB (n = 99) and unmatched controls (n = 291) and analyzed urine samples for a panel of trace metals (median: 26 weeks gestation). We used logistic regression models to calculate the odds ratio (OR) for PTB and subtypes of PTB based on presentation at delivery. Subtypes included spontaneous and placental PTB. We used elastic net (ENET) regularization to identify individual metals or pairwise interactions that had the strongest associations with PTB, and principal components analysis (PCA) to identify classes of exposures associated with the outcome. We observed increased odds of PTB (OR: 1.41, 95% Confidence Interval [CI]: 1.12, 1.78) in association with an interquartile range difference in urinary copper (Cu). We also observed an increased OR for selenium (OR: 1.33, 95% CI: 0.98, 1.81). ENET selected Cu as the most important trace metal associated with PTB. PCA identified 3 principal components (PCs) that roughly reflected exposure to toxic metals, essential metals, and metals with seafood as a common source of exposure. PCs reflecting essential metals were associated with increased odds of overall and spontaneous PTB. Maternal urinary copper in the third trimester was associated with increased risk of PTB, and statistical analyses for mixtures indicated that after accounting for correlation this metal was the most important statistical predictor of the outcome. Highlights • We analyzed 17 urinary trace metals in collaboration with the Children's Health and Exposure Assessment Resource (CHEAR). • Urinary Cu concentrations from third trimester were associated with increased odds of preterm birth in single pollutant model • Elevated concentrations of essential trace metals, Se and Zn, also had a positive association with increased odds of preterm birth • ENET and PCA results confirmed findings from the single pollutant models. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
44. Associations between maternal phenol and paraben urinary biomarkers and maternal hormones during pregnancy: A repeated measures study.
- Author
-
Aker, Amira M., Johns, Lauren, McElrath, Thomas F., Cantonwine, David E., Mukherjee, Bhramar, and Meeker, John D.
- Subjects
- *
MATERNAL health , *PHYSIOLOGICAL effects of phenol , *THYROID hormones , *PARABENS , *URINALYSIS , *BIOMARKERS , *WOMEN'S health - Abstract
Background: A number of phenols and parabens are added to consumer products for a variety of functions, and have been found at detectable levels in the majority of the U.S. population. Among other functions, thyroid hormones are essential in fetal neurodevelopment, and could be impacted by the endocrine disrupting effects of phenols and parabens. The present study investigated the association between ten maternal urinary phenol and paraben biomarkers (bisphenol S, triclosan, triclocarban, benzophenone-3, 2,4-dichlorophenol, 2,5-dichlorophenol, and ethyl, butyl, methyl and propyl paraben) and four plasma thyroid hormones in 439 pregnant women in a case–control sample nested within a cohort study based in Boston, MA. Methods: Urine and blood samples were collected from up to four visits during pregnancy (median weeks of gestation at each visit: Visit 1: 9.64, Visit 2: 17.9, Visit 3: 26.0, Visit 4: 35.1). Linear mixed models were constructed to take into account the repeated measures jointly, followed by multivariate linear regression models stratified by gestational age to explore potential windows of susceptibility. Results: We observed decreased total triiodothyronine (T3) in relation to an IQR increase in benzophenone-3 (percent change [%Δ] = −2.07; 95% confidence interval [CI] = −4.16, 0.01), butyl paraben (%Δ = −2.76; 95% CI = −5.25, −0.26) and triclosan (%Δ = −2.53; 95% CI = −4.75, −0.30), and triclocarban at levels above the LOD (%Δ = −5.71; 95% CI = −10.45, −0.97). A 2.41% increase in T3 was associated with an IQR increase in methyl paraben (95% CI = 0.58, 4.24). We also detected a negative association between free thyroxine (FT4) and propyl paraben (%Δ = −3.14; 95% CI = −6.12, −0.06), and a suggestive positive association between total thyroxine (T4) and methyl paraben (%Δ = 1.19; 95% CI = −0.10, 2.47). Gestational age-specific multivariate regression analyses showed that the magnitude and direction of some of the observed associations were dependent on the timing of exposure. Conclusion: Certain phenols and parabens were associated with altered thyroid hormone levels during pregnancy, and the timing of exposure influenced the association between phenol and paraben, and hormone concentrations. These changes may contribute to downstream maternal and fetal health outcomes. Additional research is required to replicate the associations, and determine the potential biological mechanisms underlying the observed associations. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
45. Maternal exposure to phthalates and total gestational weight gain in the LIFECODES birth cohort.
- Author
-
Boyer, Theresa M., Bommarito, Paige A., Welch, Barrett M., Meeker, John D., James-Todd, Tamarra, Cantonwine, David E., McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
- *
WEIGHT gain , *PHTHALATE esters , *MATERNAL exposure , *PREGNANT women , *COHORT analysis , *BODY mass index - Abstract
Excessive gestational weight gain contributes to adverse maternal and neonatal outcomes. Environmental exposures such as phthalates may lead to metabolic dysregulation, and studies suggest possible associations between maternal phthalate exposure and altered gestational weight gain. We assessed the association between nine maternal phthalate metabolites and measures of total gestational weight gain (pre-pregnancy to median 35.1 weeks of gestation) in a case-control study nested within LIFECODES (N = 379), a prospective birth cohort from Boston, Massachusetts (2006–2008). Our primary outcome was total gestational weight gain z score, a measure independent of gestational age that can provide a less biased estimate of this association. Our secondary outcomes were total gestational weight gain, rate of gestational weight gain, and adequacy ratio. The results were stratified by pre-pregnancy body mass index category. We found that concentrations of mono-(3-carboxypropyl) phthalate (MCPP) and mono-n-butyl phthalate (MBP) were positively associated with total gestational weight gain z scores among participants with obesity: adjusted mean difference (95% Confidence Interval [CI]) = 0.242 (0.030 – 0.455) and 0.105 (-0.002 – 0.212) corresponding to an excess weight gain of 1.81 kg and 0.77 kg at 35 weeks of gestation per interquartile range-increase in MCPP and MBP, respectively. Also, among participants with obesity, MBP demonstrated a potential non-linear relationship with gestational weight gain in cubic spline models. These findings suggest that phthalates may be related to higher gestational weight gain, specifically, among individuals with pre-pregnancy obesity. Future research should investigate whether pregnant people with obesity represent a subpopulation with sensitivity to phthalate exposures. • Associations between phthalates and gestational weight gain differed by pre-pregnancy BMI. • MCPP and MBP were associated with higher gestational weight gain among participants with obesity. • Some phthalates, including MBP, had non-linear associations with gestational weight gain. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Urinary phthalate and DINCH metabolite concentrations and gradations of maternal glucose intolerance.
- Author
-
James-Todd, Tamarra, Ponzano, Marta, Bellavia, Andrea, Williams, Paige L., Cantonwine, David E., Calafat, Antonia M., Hauser, Russ, Quinn, Marlee R., Seely, Ellen W., and McElrath, Thomas F.
- Subjects
- *
GLUCOSE intolerance , *PHTHALATE esters , *GESTATIONAL diabetes , *GLUCOSE tolerance tests , *HYPERGLYCEMIA , *PRINCIPAL components analysis , *LOGISTIC regression analysis - Abstract
[Display omitted] Studies suggest a link between pregnancy phthalate exposures and gestational diabetes mellitus (GDM). Few studies have evaluated associations between phthalate biomarkers (individual or mixtures) with gradations of maternal glucose intolerance. In a subset of 606 women participating in LIFECODES pregnancy cohort, a combination of 50-gram 1-h non-fasting glucose load test (GLT) and 100-gram 3-h fasting oral glucose tolerance test was used to determine pregnancy glycemic status (median: 27 weeks gestation): normoglycemia (n = 136), impaired glucose tolerance (IGT) (n = 296), and GDM (n = 174). Nineteen metabolites of phthalates and their replacements were measured during each trimester. We used multivariable logistic regression models to evaluate associations between biomarkers (in quartiles) and maternal glycemic status (GDM v. normoglycemia and IGT v. normoglycemia), adjusting for potential confounders. We also used principal component analysis to evaluate associations jointly accounting for metabolites as chemical mixtures. Higher 1st trimester mono-3-carboxypropyl phthalate (MCPP) was associated with decreased odds of GDM (Q4 v. Q1: 0.30; 95% CI: 0.13, 0.67) and IGT (Q4 v. Q1 OR: 0.37; 95% CI: 0.17, 0.79). Higher 2nd trimester mono-isobutyl phthalate (MiBP) was associated with increased IGT (Q4 v. Q1 OR: 2.07; 95% CI: 1.06, 4.07), and 2nd trimester mono-3-hydroxybutyl phthalate (MHBP) was non-monotonically associated with increased GDM (Q2 v. Q1 OR: 3.21; 95% CI: 1.54, 6.87). Mixture analyses showed similar associations (Q4 v. Q1 for 2nd trimester dibutyl phthalates metabotlites mixtures OR: 2.08; 95% CI: 1.04, 4.22). Some phthalate biomarkershad trimester-specific associations with glycemic outcomes, with long and short term health implications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
47. Longitudinal exposure to consumer product chemicals and changes in plasma oxylipins in pregnant women.
- Author
-
Welch, Barrett M., Keil, Alexander P., Bommarito, Paige A., van t' Erve, Thomas Joost, Deterding, Leesa J., Williams, Jason G., Lih, Fred B., Cantonwine, David E., McElrath, Thomas F., and Ferguson, Kelly K.
- Subjects
- *
OXYLIPINS , *PREGNANT women , *PHTHALATE esters , *CONSUMER goods , *LYSYL oxidase , *PANEL analysis , *LIPID metabolism - Abstract
• We evaluated class-specific mixtures of phenol, phthalate, and organophosphate ester biomarkers in maternal urine. • We assessed the bioactive lipids called oxylipins from several biosynthetic pathways in maternal plasma. • Higher consumer product chemicals were associated with certain pro-inflammatory oxylipins. • Consumer product chemicals may promote inflammation related to lipid metabolism during pregnancy. Exposure to consumer product chemicals during pregnancy may increase susceptibility to pregnancy disorders by influencing maternal inflammation. However, effects on specific inflammatory pathways have not been well characterized. Oxylipins are a diverse class of lipids that act as important mediators and biomarkers of several biological pathways that regulate inflammation. Adverse pregnancy outcomes have been associated with circulating oxylipin levels in pregnancy. In this study, we aimed to determine the longitudinal associations between plasma oxylipins and urinary biomarkers of three classes of consumer product chemicals among pregnant women. Data come from a study of 90 pregnant women nested within the LIFECODES cohort. Maternal plasma and urine were collected at three prenatal visits. Plasma was analyzed for 61 oxylipins, which were grouped according to biosynthetic pathways that we defined by upstream: 1) fatty acid precursor, including linoleic, arachidonic, docosahexaenoic, or eicosapentaenoic acid; and 2) enzyme pathway, including cyclooxygenase (COX), lipoxygenase (LOX), or cytochrome P450 (CYP). Urine was analyzed for 12 phenol, 12 phthalate, and 9 organophosphate ester (OPE) biomarkers. Linear mixed effect models were used for single-pollutant analyses. We implemented a novel extension of quantile g-computation for longitudinal data to examine the joint effect of class-specific chemical mixtures on individual plasma oxylipin concentrations. We found that urinary biomarkers of consumer product chemicals were positively associated with pro-inflammatory oxylipins from several biosynthetic pathways. Importantly, these associations depended upon the chemical class of exposure biomarker. We estimated positive associations between urinary phenol biomarkers and oxylipins produced from arachidonic acid by LOX enzymes, including several important pro-inflammatory hydroxyeicosatetraenoic acids (HETEs). On average, mean concentrations of oxylipin produced from the arachidonic acid/LOX pathway were 48%–71% higher per quartile increase in the phenol biomarker mixture. For example, a simultaneous quartile increase in all urinary phenols was associated with 53% higher (95% confidence interval [CI]: 11%, 111%) concentrations of 12-HETE. The positive associations among phenols were primarily driven by methyl paraben, 2,5-dichlorophenol, and triclosan. Additionally, we observed that phthalate and OPE metabolites were associated with higher concentrations of oxylipins produced from linoleic acid by CYP enzymes, including the pro-inflammatory dihydroxy-octadecenoic acids (DiHOMEs). Associations among DiHOME oxylipins were driven by metabolites of benzylbutyl and di-isodecyl phthalate, and by the metabolite of tris(1,3-dichloro-2-propyl) phosphate among OPEs. We also observed inverse associations between phthalate and OPE metabolites and oxylipins produced from other pathways; however, adjusting for a plasma indicator of dietary fatty acid intake attenuated those results. Our findings support the hypothesis that consumer product chemicals may have diverse impacts on inflammation processes in pregnancy. Certain pro-inflammatory oxylipins were generally higher among participants with higher urinary chemical biomarker concentrations. Associations varied by class of chemical and by the biosynthetic pathway of oxylipin production, indicating potential specificity in the inflammatory effects of these environmental chemicals during pregnancy that warrant investigation in larger studies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. Comparison of seasonal serum 25-hydroxyvitamin D concentrations among pregnant women in Mongolia and Boston.
- Author
-
Bromage, Sabri, Enkhmaa, Davaasambuu, Baatar, Tsedmaa, Garmaa, Gantsetseg, Bradwin, Gary, Yondonsambuu, Buyandelger, Sengee, Tuul, Jamts, Enkhtuya, Suldsuren, Narmandakh, McElrath, Thomas F., Cantonwine, David E., Hoover, Robert N., Troisi, Rebecca, and Ganmaa, Davaasambuu
- Subjects
- *
PREGNANT women , *VITAMIN D , *QUANTILE regression , *MOTHER-child relationship , *BONE density - Abstract
• Vitamin D levels in Mongolian third trimester pregnant women are severely depressed. • Levels in pregnant women in Boston are comparatively elevated and less seasonal. • Levels in Boston, but not Mongolia, are associated with targetable risk factors. • Mongolia should consider a combined approach of fortification and supplementation. • This joint approach is warranted in vitamin D deficiency-endemic regions globally. Adequate vitamin D status during pregnancy is important for developing fetal bone strength and density and may play a role in preventing a range of skeletal and non-skeletal diseases in both mothers and children. We previously identified Mongolian women of reproductive age to have the lowest vitamin D levels yet observed in any population globally, which renders this population uniquely important in vitamin D research. In this study, we measured the seasonal distribution of 25-hydroxyvitamin D (25(OH)D) concentration in 390 healthy third trimester pregnant women living in urban and rural Mongolia using DiaSorin LIAISON and compared this distribution to that of 206 third trimester women living in Boston, USA. Also, we analyzed seasonally-independent associations between (25(OH)D) levels and selected predictors in both groups using quantile regression. Mean 25(OH)D levels were significantly higher and less seasonal in Boston (seasonal range: 27.1 ± 7.0–31.5 ± 7.7 ng/ml) than in Mongolia (seasonal range: 11.2 ± 3.9–19.2 ± 6.7 ng/ml). Adjusting for month of blood draw, higher 25(OH)D levels were significantly associated with older age, lower gravidity, lower BMI, and lack of a college or university degree among Boston participants, however, only gravidity was robust to multivariable adjustment. No assessed characteristics were independently predictive in Mongolia, likely due to universally low 25(OH)D levels and a resulting lack of between-person variation. In conclusion, vitamin D status among pregnant Mongolians is severely depressed throughout the year and should be addressed through fortification and supplementation, while in the U.S., deficiency is associated with specific characteristics targetable through supplementation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.